Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenomedullin Does Not Inhibit Human Platelet Aggregation.

Schiller1, Champion, Hugghins

  • 1Departments of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA

Journal of Cardiovascular Pharmacology and Therapeutics
|February 23, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rules for the Administration of Chloroform in Labor.

Iowa medical journal·2023
Same author

On Certain Forms of Headache.

The North-Western medical and surgical journal·2023
Same author

Twins Locked in Each Other.

The North-Western medical and surgical journal·2023
Same author

Gonorrhea as a Social Problem.

Atlanta journal-record of medicine·2022
Same author

Report on the Use of Apomorphia in Sunstroke.

The Indian medical gazette·2017
Same author

Acute appendicitis simulating rheumatic fever.

Clinical proceedings - Children's Hospital of the District of Columbia·2010
Same journal

Effects of Vericiguat on Peripheral Vascular Function and Resting/Exercise Hemodynamics in Patients With Heart Failure With Reduced Ejection Fraction: An Exploratory Pilot Study.

Journal of cardiovascular pharmacology and therapeutics·2026
Same journal

Norepinephrine Versus Dopamine as Vasoactive Therapy in Cardiogenic Shock: Association With 28-Day Mortality in a Retrospective Cohort Study.

Journal of cardiovascular pharmacology and therapeutics·2026
Same journal

ABCD-GENE Score and Bleeding in Post-PCI Patients: Implications for Guided De-Escalation of Antiplatelet Therapy.

Journal of cardiovascular pharmacology and therapeutics·2026
Same journal

Alterations of Platelet MicroRNAs Associated With Dapagliflozin Treatment in Individuals With Type 2 Diabetes Mellitus.

Journal of cardiovascular pharmacology and therapeutics·2026
Same journal

Comparative Effectiveness of Renin-Angiotensin System Inhibitors in Heart Failure With Nonreduced Ejection Fraction: A Multicenter Cohort Study.

Journal of cardiovascular pharmacology and therapeutics·2026
Same journal

Shared Genetic Liability Between Heart Failure and Myocardial Infarction Revealed by Genome-Wide Cross-Trait Analysis.

Journal of cardiovascular pharmacology and therapeutics·2026
See all related articles

Adrenomedullin (ADM) does not inhibit human platelet aggregation, despite increasing cyclic adenosine monophosphate (cAMP) levels. This suggests human platelets lack a functional ADM receptor linked to adenylate cyclase.

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology

Background:

  • Adrenomedullin (ADM), a hypotensive peptide, elevates cyclic adenosine monophosphate (cAMP) levels.
  • Elevating cAMP typically inhibits platelet aggregation.

Purpose of the Study:

  • To investigate the effect of ADM on human platelet aggregation.
  • To determine if ADM influences adenosine 5'-diphosphate (ADP)-induced platelet aggregation.

Main Methods:

  • Human platelet-rich plasma was incubated with varying concentrations of ADM.
  • Platelet aggregation was measured following stimulation with adenosine 5'-diphosphate (ADP).
  • Prostaglandin E1 (PGE1) was used as a positive control for inhibition.

Main Results:

  • ADM did not alter adenosine 5'-diphosphate (ADP)-induced human platelet aggregation.

Related Experiment Videos

  • Prostaglandin E1 (PGE1) effectively inhibited ADP-induced platelet aggregation.
  • ADM induced a dose-dependent response in human chorionic artery rings.

    • Conclusions:

    • Human platelets appear to lack a functional Adrenomedullin (ADM) receptor coupled to adenylate cyclase.
    • ADM's hypotensive effects may not be mediated through direct platelet inhibition via cAMP in humans.